Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/24 17:20 | 3/11/24 | XFOR | Health | BioPrd | Biological Products, (No Diag | Taveras Arthur | MA | O | Chief Sc | 5 | S | -78 | 0.7739 | 0 | -100 | 249 | D | |||||||||||||||
3/11/24 17:20 | 3/11/24 | XFOR | Health | BioPrd | Biological Products, (No Diag | Ragan Paula | MA | DO | P,CEO | 8 | S.m | -349 | 0.8693 | 0 | -402 | 836 | D | |||||||||||||||
3/11/24 17:19 | 3/11/24 | XFOR | Health | BioPrd | Biological Products, (No Diag | Mostafa Adam S. | MA | O | CFO | 8 | S | -340 | 0.8405 | 0 | -405 | 146 | D | |||||||||||||||
3/11/24 17:19 | 3/11/24 | XFOR | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | 9 | S | -94 | 0.8216 | 0 | -114 | 311 | D | |||||||||||||||
11/3/23 16:39 | 11/1/23 | XFOR | Health | BioPrd | Biological Products, (No Diag | Baldry Mark | MA | O | Chief Co | 1 | S | -7 | 0.7300 | 0 | -10 | 25 | D | |||||||||||||||
8/11/23 19:26 | 8/10/23 | XFOR | Health | BioPrd | Biological Products, (No Diag | Stewart Murray | MA | DO | Interim | 1 | S | -138 | 1.06 | 0 | -130 | 147 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |